GO:0035621 ER to Golgi ceramide transport: Lipid Trafficking Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035621 describes the directed movement of ceramide from the endoplasmic reticulum (ER) to the Golgi apparatus, a key step in sphingolipid metabolism.
• Ceramide reaches the Golgi by both vesicular and non-vesicular mechanisms; the non-vesicular route is mediated by the ceramide transfer protein CERT (STARD11/COL4A3BP).
• An inducible ER-Golgi tether can facilitate ceramide transport to alleviate lipotoxicity, showing that this process is dynamically regulated.
• CERT also participates in the ER-to-Golgi transfer of alkylacylglycerol for ether phospholipid biosynthesis, linking ceramide transport to broader lipid pathways.
• ER-to-Golgi ceramide traffic is stimulated by sphingosine 1-phosphate and supports survival in glioma cells, connecting this GO term to cancer biology.
• ER-Golgi-localized proteins TMED2 and TMED10 control plasma membrane lipid nanodomain formation, indicating that ceramide transport influences membrane organization.
Description
ER to Golgi ceramide transport (GO:0035621) is the biological process that mediates the directed movement of ceramide, a sphingosine-based lipid, from the endoplasmic reticulum (ER) to the Golgi apparatus. Ceramide is synthesized in the ER and must be delivered to the Golgi, where it is converted into more complex sphingolipids such as sphingomyelin and glycosphingolipids. This transport step is therefore a central node in sphingolipid metabolism and membrane lipid homeostasis. Researchers study GO:0035621 because defects or alterations in ceramide trafficking are linked to lipotoxicity, cancer cell survival, and membrane domain organization. The process occurs through both vesicular and non-vesicular routes, with the non-vesicular pathway relying on lipid transfer proteins such as CERT. Understanding the molecular players and regulatory logic of ER to Golgi ceramide transport is essential for dissecting how cells balance lipid synthesis, transport, and storage.
ER to Golgi ceramide transport At A Glance
| GO ID | GO:0035621 |
|---|---|
| GO term | ER to Golgi ceramide transport |
| Ontology | biological_process |
| Synonym | endoplasmic reticulum to Golgi ceramide transport; ER to Golgi ceramide translocation; non-vesicular ceramide trafficking |
| Major function | Directed movement of ceramide from the ER to the Golgi for sphingolipid synthesis and membrane lipid homeostasis |
| Definition source | QuickGO definition: The directed movement of a ceramide from the endoplasmic reticulum (ER) to the Golgi. Ceramides are a class of lipid composed of sphingosine linked to a fatty acid. |
| Related processes | Sphingolipid metabolism, ceramide synthesis, membrane lipid transport, ether phospholipid biosynthesis |
| Key transport mode | Vesicular and non-vesicular (CERT-dependent) mechanisms |
| Cellular context | ER-Golgi membrane contact sites and secretory pathway |
What Is GO:0035621?
In our own words, GO:0035621 describes the directed, protein-assisted movement of ceramide molecules from the endoplasmic reticulum to the Golgi apparatus. Ceramide is a lipid composed of sphingosine linked to a fatty acid. This transport can occur through vesicular carriers or through non-vesicular transfer mediated by lipid transfer proteins. The term encompasses the machinery, tethers, and transfer proteins that ensure ceramide reaches the Golgi for downstream sphingolipid synthesis.
Why Is ER to Golgi ceramide transport Important in Cell Biology?
ER to Golgi ceramide transport is important because it sits at the intersection of lipid synthesis, membrane trafficking, and cell survival. Ceramide produced in the ER must reach the Golgi to be converted into sphingomyelin and glycosphingolipids, and failure of this delivery can cause lipotoxicity. The process is also dynamically regulated: an inducible ER-Golgi tether can enhance ceramide transport to alleviate lipotoxic stress. In cancer cells, sphingosine 1-phosphate stimulates ER to Golgi ceramide traffic to promote survival, linking this transport step to tumor cell biology. Moreover, CERT, the principal non-vesicular ceramide transfer protein, also participates in transferring alkylacylglycerol for ether phospholipid biosynthesis, showing that ceramide transport is integrated with broader lipid metabolic networks. Finally, ER-Golgi-localized proteins such as TMED2 and TMED10 influence plasma membrane lipid nanodomains, indicating that ceramide transport contributes to membrane organization and signaling.
• Ceramide must be transported from the ER to the Golgi for conversion into complex sphingolipids such as sphingomyelin and glycosphingolipids.
• Non-vesicular ceramide transfer by CERT is a major route for ER-to-Golgi ceramide delivery.
• Inducible ER-Golgi tethering can facilitate ceramide transport and alleviate lipotoxicity.
• Sphingosine 1-phosphate stimulates ER to Golgi ceramide traffic to promote survival in glioma cells.
• CERT is involved in alkylacylglycerol transfer from the ER to the Golgi for ether phospholipid biosynthesis.
• ER-Golgi-localized TMED2 and TMED10 control plasma membrane lipid nanodomain formation.
• Defects in ceramide trafficking can disrupt membrane lipid homeostasis and contribute to disease.
• The process is conserved across eukaryotes, including yeast and plants.
• Understanding this pathway supports research on cancer, lipotoxicity, and lipid storage disorders.
• Ceramide transport is a potential target for modulating sphingolipid-dependent signaling.
What Happens During ER to Golgi ceramide transport?
Ceramide synthesis in the ER
In simple terms: Ceramide is made in the ER before it can be moved to the Golgi.
Ceramide is synthesized in the endoplasmic reticulum as part of sphingolipid metabolism. This newly generated ceramide is the substrate for ER to Golgi transport (GO:0035621). The ER therefore serves as the starting point for the directed movement of ceramide to the Golgi.
Vesicular and non-vesicular transport routes
In simple terms: Ceramide can travel to the Golgi either inside vesicles or with the help of carrier proteins.
Ceramide moves from the ER to the Golgi by both vesicular and non-vesicular mechanisms. In yeast, both routes contribute to ER-to-Golgi ceramide transport. Non-vesicular ceramide transport is mediated by lipid transfer proteins such as CERT, which extract ceramide from the ER and deliver it to the Golgi. The existence of multiple routes highlights the importance and redundancy of this transport step.
CERT-mediated non-vesicular transfer
In simple terms: CERT is a shuttle protein that carries ceramide from the ER to the Golgi.
The ceramide transport protein CERT is a key mediator of non-vesicular ER to Golgi ceramide transport. CERT is also involved in alkylacylglycerol transfer from the ER to the Golgi for ether phospholipid biosynthesis, indicating that it handles multiple lipid cargoes. This dual role links ceramide transport to broader ER-to-Golgi lipid trafficking.
ER-Golgi tethering and dynamic regulation
In simple terms: The ER and Golgi can be physically connected to help ceramide move and to protect cells from lipid stress.
An inducible ER-Golgi tether facilitates ceramide transport to alleviate lipotoxicity. This indicates that the spatial relationship between the ER and Golgi is dynamically regulated to control ceramide delivery. In plant cells, ER-to-Golgi trafficking occurs through a dynamic intermediate cis-Golgi tubular network, showing that ER-Golgi connectivity is a conserved theme.
Delivery to the Golgi and downstream metabolism
In simple terms: Once ceramide reaches the Golgi, it is used to build more complex lipids.
After arriving at the Golgi, ceramide is converted into downstream sphingolipids such as sphingomyelin and glycosphingolipids. This conversion is part of the broader sphingolipid metabolic pathway that spans synthesis, transport, and breakdown. The delivery step therefore determines the availability of ceramide for Golgi-based lipid synthesis.
Impact on membrane organization
In simple terms: Ceramide transport affects how lipids are organized in the cell membrane.
ER-Golgi-localized proteins TMED2 and TMED10 control the formation of plasma membrane lipid nanodomains. This suggests that ceramide transport and related ER-Golgi lipid trafficking influence the organization of signaling platforms at the plasma membrane. Such nanodomains are important for membrane protein function and signal transduction.
Key Genes Involved in GO:0035621 ER to Golgi ceramide transport
The following genes and proteins are experimentally implicated in ER to Golgi ceramide transport (GO:0035621) and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CERT (STARD11/COL4A3BP) | Non-vesicular ceramide transfer from ER to Golgi | Central mediator of GO:0035621; target for lipid trafficking studies |
| TMED2 | ER-Golgi-localized protein controlling lipid nanodomain formation | Links ceramide transport to plasma membrane organization |
| TMED10 | ER-Golgi-localized protein controlling lipid nanodomain formation | Links ceramide transport to plasma membrane organization |
| Sphingosine 1-phosphate signaling components | Stimulate ER to Golgi ceramide traffic | Promote survival in glioma cells |
| ER-Golgi tether components | Facilitate ceramide transport to alleviate lipotoxicity | Inducible tethering as a regulatory mechanism |
| Alkylacylglycerol transfer machinery | CERT-dependent transfer for ether phospholipid biosynthesis | Connects ceramide transport to ether lipid metabolism |
| Yeast ceramide transport proteins | Vesicular and non-vesicular ER-to-Golgi ceramide transport | Model system for conserved transport mechanisms |
| Plant ER-Golgi trafficking proteins | ER-to-Golgi trafficking via cis-Golgi tubular network | Comparative cell biology of ER-Golgi transport |
| Sphingolipid metabolic enzymes | Synthesis and breakdown of ceramide and complex sphingolipids | Provide context for ceramide flux through the Golgi |
| Non-vesicular lipid transfer proteins | Mechanisms of non-vesicular ceramide transport | General principles of lipid transfer at contact sites |
| Membrane contact site proteins | ER-Golgi tethering and lipid exchange | Spatial regulation of ceramide delivery |
| Lipid nanodomain regulators | Plasma membrane lipid organization | Downstream consequences of ceramide transport |
| Ether phospholipid biosynthetic enzymes | Utilize ER-to-Golgi transferred alkylacylglycerol | Metabolic intersection with ceramide transport |
| Glioma survival signaling proteins | S1P-stimulated ceramide traffic | Cancer cell survival context |
| Yeast secretory pathway components | Vesicular transport of ceramide | Genetic dissection of transport routes |
| Plant cis-Golgi network proteins | Dynamic intermediate cis-Golgi tubular network | Plant-specific ER-to-Golgi trafficking |
How Is ER to Golgi ceramide transport Regulated?
ER to Golgi ceramide transport is regulated at multiple levels. An inducible ER-Golgi tether can be engaged to facilitate ceramide transport and alleviate lipotoxicity, indicating that the physical connection between the ER and Golgi is dynamically controlled. Sphingosine 1-phosphate stimulates ER to Golgi ceramide traffic to promote survival in T98G glioma cells, showing that lipid signaling can upregulate this transport step. CERT-mediated non-vesicular transfer is a key regulated node, and CERT also participates in alkylacylglycerol transfer for ether phospholipid biosynthesis, linking ceramide transport to broader lipid metabolic demand. In plant cells, ER-to-Golgi trafficking through a dynamic intermediate cis-Golgi tubular network suggests that membrane remodeling and tubular intermediates contribute to regulation of ER-Golgi exchange. Together, these findings indicate that ER to Golgi ceramide transport is not constitutive but responds to cellular lipid status and stress.
ER to Golgi ceramide transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CERT (STARD11/COL4A3BP) | Ceramide trafficking and ether phospholipid metabolism | Knockout or point-mutation cell models to assess ceramide delivery |
| S1P signaling components | Glioma cell survival | Overexpression or knockout in T98G glioma cells |
| TMED2 | Plasma membrane lipid nanodomain formation | Knockout and tagged knock-in for localization studies |
| TMED10 | Plasma membrane lipid nanodomain formation | Knockout and tagged knock-in for localization studies |
| ER-Golgi tether components | Lipotoxicity | Inducible tether knock-in or overexpression models |
Cancer and glioma cell survival
Sphingosine 1-phosphate stimulates ER to Golgi ceramide traffic to promote survival in T98G glioma cells. This links GO:0035621 to cancer cell biology, where altered sphingolipid trafficking can support survival signaling. Ceramide transport may therefore influence the balance between pro-apoptotic ceramide and pro-survival sphingolipid metabolites.
Lipotoxicity and metabolic stress
An inducible ER-Golgi tether facilitates ceramide transport to alleviate lipotoxicity, indicating that impaired ceramide delivery can contribute to lipid-induced cellular stress. This connects ER to Golgi ceramide transport to metabolic disorders characterized by lipid overload. Enhancing ceramide transport may be a protective response under lipotoxic conditions.
Membrane organization and signaling
ER-Golgi-localized proteins TMED2 and TMED10 control the formation of plasma membrane lipid nanodomains, which are important for signaling and membrane protein function. Because ceramide transport influences Golgi lipid composition, defects in GO:0035621 could indirectly affect nanodomain-dependent processes. This provides a mechanistic link between ceramide trafficking and membrane-associated disease mechanisms.
Ether phospholipid-related metabolism
CERT is involved in alkylacylglycerol transfer from the ER to the Golgi for the biosynthesis of ether phospholipids. Ether phospholipids are important membrane components, and their production is tied to ER-to-Golgi lipid transfer. Perturbations in this pathway may affect cellular lipid homeostasis and related disease states.
From ER to Golgi ceramide transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CERT block ER to Golgi ceramide transport? | CERT knockout cell line |
| Can an inducible ER-Golgi tether alleviate lipotoxicity? | Inducible tether knock-in or overexpression model |
| How does S1P stimulate ceramide traffic in glioma? | Overexpression or knockout of S1P signaling components in T98G cells |
| Do TMED2/TMED10 control lipid nanodomains? | TMED2 or TMED10 knockout and tagged knock-in |
| Is CERT required for ether phospholipid biosynthesis? | CERT point-mutation or knockout cells |
| Are vesicular and non-vesicular routes conserved? | Yeast genetic models |
How to Study the ER to Golgi ceramide transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent ceramide tracing | ER-to-Golgi ceramide movement | Live-cell imaging of transport routes |
| Lipidomics (mass spectrometry) | Ceramide and sphingolipid levels | Quantifying flux through the pathway |
| Knockout genetics | Requirement of specific genes | Testing CERT or tether components |
| Tagged knock-in imaging | Protein localization at ER-Golgi sites | Studying CERT, TMED2, TMED10 |
| Co-immunoprecipitation | Protein-protein interactions | Identifying transport complex components |
| Yeast genetic screens | Vesicular vs non-vesicular transport | Dissecting conserved mechanisms |
| Plant cell imaging | ER-to-Golgi tubular network dynamics | Comparative trafficking studies |
| Lipotoxicity assays | Cell survival under lipid stress | Testing tether-mediated rescue |
Lipid tracing and imaging
Fluorescent ceramide analogs and live-cell imaging can track ER-to-Golgi ceramide movement and assess the contribution of vesicular versus non-vesicular routes. Imaging ER-Golgi contact sites and tubular intermediates helps visualize the spatial organization of transport. These approaches are essential for directly observing GO:0035621 in cells.
Genetic perturbation and knockout studies
Knockout of CERT or other transport components can be used to test requirement for ER to Golgi ceramide transport. Yeast genetics has been instrumental in dissecting vesicular and non-vesicular ceramide transport pathways. Such perturbation studies link specific genes to the GO:0035621 process.
Lipidomics and metabolic profiling
Mass spectrometry-based lipidomics can quantify ceramide and downstream sphingolipids to infer transport efficiency. Changes in sphingomyelin and glycosphingolipid levels reflect flux through the ER-to-Golgi ceramide transport step. Lipidomics also detects ether phospholipid changes when CERT function is altered.
Protein interaction and localization assays
Tagged knock-in of CERT, TMED2, or TMED10 allows localization and interaction studies at ER-Golgi contact sites. Co-immunoprecipitation and proximity labeling can identify proteins that regulate ceramide transport. These methods help define the molecular machinery of GO:0035621.
How CRISPR Can Be Used to Study GO:0035621 ER to Golgi ceramide transport
Knockout
CRISPR knockout of CERT or other candidate genes can test whether they are required for ER to Golgi ceramide transport. Knockout of TMED2 or TMED10 can reveal their role in lipid nanodomain formation downstream of ceramide delivery. Yeast knockout models complement mammalian studies by dissecting vesicular and non-vesicular routes.
Point Mutation
Point mutations in CERT can separate its ceramide transfer function from its alkylacylglycerol transfer role in ether phospholipid biosynthesis. Such mutations help define the substrate specificity and regulatory domains of transport proteins. Point-mutation models are valuable for linking specific residues to GO:0035621 activity.
Knock-in
Knock-in of inducible ER-Golgi tethers can be used to enhance ceramide transport and test whether this alleviates lipotoxicity. Tagged knock-in of CERT, TMED2, or TMED10 enables precise localization and interaction studies at ER-Golgi contact sites. These models allow dynamic control of the transport process in living cells.
Overexpression
Overexpression of CERT or S1P signaling components can boost ER to Golgi ceramide traffic and promote survival in glioma cells. Overexpression models are useful for testing whether increased transport capacity changes lipid composition and cell fate. They also help identify rate-limiting steps in the pathway.
How EDITGENE Supports ER to Golgi ceramide transport Research
Researchers studying ER to Golgi ceramide transport-related genes often need to determine whether a candidate gene is causally involved in ceramide delivery, membrane lipid organization, or downstream sphingolipid synthesis. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of these pathways.
Contact EDITGENE today to design your custom CRISPR model for ER to Golgi ceramide transport research.
Frequently Asked Questions About ER to Golgi ceramide transport
What is ER to Golgi ceramide transport?
ER to Golgi ceramide transport (GO:0035621) is the directed movement of ceramide from the endoplasmic reticulum to the Golgi apparatus, a key step in sphingolipid metabolism.
What genes are involved in ER to Golgi ceramide transport?
Key genes include CERT (STARD11/COL4A3BP), TMED2, TMED10, and components of sphingosine 1-phosphate signaling and ER-Golgi tethering.
Is ER to Golgi ceramide transport vesicular or non-vesicular?
Both vesicular and non-vesicular mechanisms contribute to ER-to-Golgi ceramide transport, with CERT mediating the non-vesicular route.
What is the role of CERT in ceramide transport?
CERT is a ceramide transfer protein that mediates non-vesicular ER to Golgi ceramide transport and is also involved in alkylacylglycerol transfer for ether phospholipid biosynthesis.
How is ER to Golgi ceramide transport regulated?
It can be regulated by inducible ER-Golgi tethering to alleviate lipotoxicity and by sphingosine 1-phosphate signaling to promote survival in glioma cells.
Why is ER to Golgi ceramide transport important in cancer?
Sphingosine 1-phosphate stimulates ER to Golgi ceramide traffic to promote survival in T98G glioma cells, linking this process to cancer cell survival.
What methods are used to study ER to Golgi ceramide transport?
Fluorescent ceramide tracing, lipidomics, knockout genetics, tagged knock-in imaging, and co-immunoprecipitation are commonly used.
Can CRISPR be used to study ER to Golgi ceramide transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect gene function in this pathway.
What is the connection between ceramide transport and lipotoxicity?
An inducible ER-Golgi tether facilitates ceramide transport to alleviate lipotoxicity, indicating that impaired transport contributes to lipid-induced stress.
How does ceramide transport affect membrane organization?
ER-Golgi-localized proteins TMED2 and TMED10 control plasma membrane lipid nanodomain formation, linking ceramide transport to membrane organization.
Conclusion
ER to Golgi ceramide transport (GO:0035621) is a central lipid trafficking process that delivers ceramide from its site of synthesis in the ER to the Golgi for conversion into complex sphingolipids. It occurs through both vesicular and non-vesicular routes, with CERT playing a major role in the non-vesicular pathway. The process is dynamically regulated by ER-Golgi tethering and lipid signaling, and it influences lipotoxicity, cancer cell survival, and membrane nanodomain organization. Studying GO:0035621 with CRISPR-based models and lipidomics will continue to reveal how cells coordinate lipid transport with metabolic and signaling demands.
References
- 1. Gault CR et al.. 2010. An overview of sphingolipid metabolism: from synthesis to breakdown.. Adv Exp Med Biol 688:1-23 PMID: 20919643
- 2. Liu LK et al.. 2017. An inducible ER-Golgi tether facilitates ceramide transport to alleviate lipotoxicity.. J Cell Biol 216(1):131-147 PMID: 28011845
- 3. Giussani P et al.. 2024. Sphingosine 1-Phosphate Stimulates ER to Golgi Ceramide Traffic to Promote Survival in T98G Glioma Cells.. Int J Mol Sci 25(15) PMID: 39125841
- 4. Horibata Y et al.. 2024. The ceramide transport protein CERT is involved in alkylacylglycerol transfer from the ER to the Golgi for the biosynthesis of ether phospholipid.. Arch Biochem Biophys 752:109871 PMID: 38110110
- 5. Fougère L et al.. 2025. ER-to-Golgi trafficking through a dynamic intermediate cis-Golgi tubular network in Arabidopsis.. Nat Cell Biol 27(3):424-437 PMID: 40000850
- 6. Clausmeyer L et al.. 2023. Mechanisms of Nonvesicular Ceramide Transport.. Contact (Thousand Oaks) 6:25152564231208250 PMID: 37859671
- 7. Anwar MU et al.. 2022. ER-Golgi-localized proteins TMED2 and TMED10 control the formation of plasma membrane lipid nanodomains.. Dev Cell 57(19):2334-2346.e8 PMID: 36174556
- 8. Funato K et al.. 2001. Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast.. J Cell Biol 155(6):949-59 PMID: 11733544
